HEPA · Hepion Pharmaceuticals, Inc.

Substantial doubt about the company's ability to continue as a going concern.

“These condensed consolidated financial statements have been prepared under the assumption that we will continue as a going concern. Due to our recurring and expected continuing losses from operations, we have concluded there is substantial doubt in our ability to continue as a going concern within one year of the issuance of these condensed consolidated financial statements without additional capital becoming available to us.”